MedPath

Hyperglycaemia and Ambulatory Anaesthesia

Completed
Conditions
stresshyperglycemie
10018424
Registration Number
NL-OMON35862
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
1000
Inclusion Criteria

* Willing and able to give written informed consent
* Scheduled for ambulant surgery
* Age 18-85 years

Exclusion Criteria

* Any condition that the local investigator feels would interfere with trial participation or the evaluation of results

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary endpoints will be mean glucose change during ambulant surgery as<br /><br>compared to presurgery fasting glucose, proportion patients reaching a glucose<br /><br>value of * 7.8 mmol/l during admission, association between patients with<br /><br>glucose of * 7.8 mmol and seeking any medical help within the first 30 days<br /><br>after discharge.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints will include mean change in glucose during surgery analyzed<br /><br>with specific tests; predictive regression model for perioperative<br /><br>hyperglycaemia; and the association between glucose change and any complication<br /><br>within the first 60 days after discharge.</p><br>
© Copyright 2025. All Rights Reserved by MedPath